Comparative Analysis of Primary and Second Primary Multiple Myeloma: A Propensity Score-Matched Study
Patients with SPMM, most of whom had well-controlled primary cancers, received active treatment and demonstrated clinical outcomes not significantly different from those with primary MM. These findings support the use of aggressive treatment strategies for SPMM. Larger prospective studies are warranted to establish optimal treatment strategies.
Authors
- Im Il Na (ORCID: https://orcid.org/0000-0002-3872-6179)
- Joonseog Kong (ORCID: https://orcid.org/0000-0002-8773-6517)
- Hye Jin Kang (ORCID: https://orcid.org/0000-0001-9067-9050)
- Heyjin Kim (ORCID: https://orcid.org/0000-0002-2213-2579)
- Hyo‐Rak Lee
- Yoon Jung Jang (ORCID: https://orcid.org/0000-0001-5186-136X)
- Chulkue Pak
Institutions
- Korea Institute of Radiological and Medical Sciences (KR)
- Na Eun Hospital (KR)
Publication Details
- Journal
- Clinical Medicine Insights Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/11795549251377882
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00